| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |